Sgambato A - Search Results

1

Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients.

Baldini E, Camerini A, Sgambato A, Prochilo T, Capodanno A, Pasqualetti F, Orlandini C, Resta L, Bevilacqua G, Collecchi P. Baldini E, et al. Among authors: sgambato a. Anticancer Res. 2006 Nov-Dec;26(6B):4415-21. Anticancer Res. 2006. PMID: 17201163 Free article.

2

Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy.

Sgambato A, Camerini A, Collecchi P, Graziani C, Bevilacqua G, Capodanno A, Migaldi M, Masciullo V, Scambia G, Rossi G, Cittadini A, Amoroso D. Sgambato A, et al. Cancer Sci. 2009 Jun;100(6):1026-33. doi: 10.1111/j.1349-7006.2009.01141.x. Epub 2009 Mar 31. Cancer Sci. 2009. PMID: 19385967 Free PMC article.

3

Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac Toxicity.

Canale ML, Camerini A, Huqi A, Lilli A, Bisceglia I, Parrini I, Lestuzzi C, Del Meglio J, Donati S, Venturini E, Sgambato A, Tarantini L, Amoroso D, Casolo G. Canale ML, et al. Among authors: sgambato a. Anticancer Res. 2019 Oct;39(10):5741-5745. doi: 10.21873/anticanres.13775. Anticancer Res. 2019. PMID: 31570476

4

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, Capelli G, Trentini GP, Cittadini A. Sgambato A, et al. Am J Pathol. 2003 Mar;162(3):849-60. doi: 10.1016/S0002-9440(10)63881-3. Am J Pathol. 2003. PMID: 12598319 Free PMC article.

5

Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone-receptor-positive metastatic breast cancer patients.

Camerini A, Rondini M, Garrone O, Valsuani C, Donati S, Siclari O, Sgambato A, Tartarelli G, Vincenti M, Mattiot VP, Porta RP, Puccetti C, Puccinelli P, Amoroso D. Camerini A, et al. Among authors: sgambato a. Cancer Biol Ther. 2009 Aug;8(15):1450-5. doi: 10.4161/cbt.8.15.8959. Epub 2009 Aug 8. Cancer Biol Ther. 2009. PMID: 19556864 Free article. Clinical Trial.

6

Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis.

Sgambato A, Zannoni GF, Faraglia B, Camerini A, Tarquini E, Spada D, Cittadini A. Sgambato A, et al. Gynecol Oncol. 2004 Mar;92(3):776-83. doi: 10.1016/j.ygyno.2003.12.008. Gynecol Oncol. 2004. PMID: 14984940

7

Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.

Sgambato A, Camerini A, Amoroso D, Genovese G, De Luca F, Cecchi M, Migaldi M, Rettino A, Valsuani C, Tartarelli G, Donati S, Siclari O, Rossi G, Cittadini A. Sgambato A, et al. Cancer Biol Ther. 2007 Dec;6(12):1840-6. doi: 10.4161/cbt.6.12.4983. Epub 2007 Sep 5. Cancer Biol Ther. 2007. PMID: 18087214 Free article.

8

Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.

Sgambato A, Camerini A, Genovese G, De Luca F, Viacava P, Migaldi M, Boninsegna A, Cecchi M, Sepich CA, Rossi G, Arena V, Cittadini A, Amoroso D. Sgambato A, et al. Cancer Sci. 2010 Sep;101(9):2080-6. doi: 10.1111/j.1349-7006.2010.01644.x. Cancer Sci. 2010. PMID: 20626751 Free PMC article.

9

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells.

Sgambato A, Camerini A, Faraglia B, Ardito R, Bianchino G, Spada D, Boninsegna A, Valentini V, Cittadini A. Sgambato A, et al. J Cell Physiol. 2004 Oct;201(1):97-105. doi: 10.1002/jcp.20045. J Cell Physiol. 2004. PMID: 15281092

10

Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells.

Sgambato A, Camerini A, Faraglia B, Pavoni E, Montanari M, Spada D, Losasso C, Brancaccio A, Cittadini A. Sgambato A, et al. Cancer Biol Ther. 2004 Oct;3(10):967-75. doi: 10.4161/cbt.3.10.1132. Epub 2004 Oct 2. Cancer Biol Ther. 2004. PMID: 15467432 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters